Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity and Capitalization - Narrative (Details)

v3.23.1
Stockholders’ Equity and Capitalization - Narrative (Details)
 1 Months Ended 2 Months Ended 12 Months Ended
Dec. 15, 2022
USD ($)
Nov. 10, 2022
USD ($)
shares
Mar. 02, 2022
shares
Sep. 29, 2021
USD ($)
$ / shares
shares
Jul. 26, 2021
USD ($)
$ / shares
shares
Sep. 30, 2021
shares
Jul. 31, 2021
shares
Sep. 27, 2021
USD ($)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Nov. 17, 2022
$ / shares
Feb. 05, 2021
shares
Class of Stock [Line Items]                        
Common stock, shares authorized (in shares)                 5,000,000,000     5,000,000,000
Preferred stock, shares authorized (in shares)                 50,000,000     50,000,000
Proceeds from pre-funded warrant exercises | $                 $ 1,967 $ 11,800    
Common stock issuance costs | $                 $ 0 $ 935,260    
Common stock issued for services (in shares)   416,270,514 150,000                  
Restricted stock units | $ $ 1,333,333                      
Emerald Health Therapeutics Inc                        
Class of Stock [Line Items]                        
Common stock issuance costs | $   $ 25,511                    
Exchange ratio   1.95                    
September 2021 Financing                        
Class of Stock [Line Items]                        
Sale of stock, gross aggregate proceeds | $       $ 6,998,034                
Term (Years)       5 years                
September 2021 Financing | Common Stock                        
Class of Stock [Line Items]                        
Number of shares issued in transaction (in shares)       58,111,112                
Two Thousand And Twenty One Inducement And Financing                        
Class of Stock [Line Items]                        
Common stock issuance costs | $               $ 935,260        
Net proceeds from the transaction | $               $ 6,062,774        
2021 Inducement Warrants                        
Class of Stock [Line Items]                        
Warrants exercise (in shares)         21,166,667              
Exercise price (in dollars per share) | $ / shares         $ 0.06       $ 0.15      
Proceeds from pre-funded warrant exercises | $         $ 1,270,000              
Term (Years)                 5 years      
2021 Inducement Warrants | July 2021 Inducement Warrants                        
Class of Stock [Line Items]                        
Exercise price (in dollars per share) | $ / shares         $ 0.15              
Number of shares issued in transaction (in shares)         21,166,667   21,166,667          
2021 Pre-Funded Warrants | September 2021 Financing                        
Class of Stock [Line Items]                        
Exercise price (in dollars per share) | $ / shares       $ 0.0001                
Number of shares issued in transaction (in shares)       19,666,667                
Sale price (in dollars per share) | $ / shares       $ 0.0899                
2021 Common Stock Warrants                        
Class of Stock [Line Items]                        
Exercise price (in dollars per share) | $ / shares                 $ 0.09      
Term (Years)                 5 years      
2021 Common Stock Warrants | September 2021 Financing                        
Class of Stock [Line Items]                        
Exercise price (in dollars per share) | $ / shares       $ 0.09                
Number of shares issued in transaction (in shares)       77,777,779                
Sale price (in dollars per share) | $ / shares       $ 0.09                
2022 Common Stock Warrants to Service Provider                        
Class of Stock [Line Items]                        
Exercise price (in dollars per share) | $ / shares                 $ 0.04      
Term (Years)                 2 years      
2022 Common Stock Warrants to Service Provider | Two Thousand And Twenty One Inducement And Financing                        
Class of Stock [Line Items]                        
Number of shares issued in transaction (in shares)               6,926,112        
Percentage of total shares of common stock and pre-funded warrants sold in offering               7.00%        
Pre-Funded Warrants                        
Class of Stock [Line Items]                        
Warrants exercise (in shares)                 19,666,667 11,800,000    
Proceeds from pre-funded warrant exercises | $                 $ 1,967 $ 11,800    
Intrinsic value of warrant exercises | $                 $ 1,178,033 $ 460,200    
Warrant exercises (in shares)                 19,666,667 11,800,000    
Pre-Funded Warrants | September 2021 Financing                        
Class of Stock [Line Items]                        
Number of shares issued in transaction (in shares)           19,666,667            
Common Stock Warrants                        
Class of Stock [Line Items]                        
Warrants exercise (in shares)                   116,666,668    
Exercise price (in dollars per share) | $ / shares                     $ 0.017  
Proceeds from pre-funded warrant exercises | $                   $ 6,999,999    
Intrinsic value of warrant exercises | $                   $ 8,764,967    
Warrant exercises (in shares)                   116,666,668    
Common Stock Warrants | September 2021 Financing                        
Class of Stock [Line Items]                        
Number of shares issued in transaction (in shares)           77,777,779